Cheung YT, Brinkman TM, Mulrooney DA, Mzayek Y, Liu W, Banerjee P, Panoskaltsis Mortari A, Srivastava D, Pui CH, Robison LL, Hudson MM, & Krull KR. Impact of sleep, fatigue and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia. Cancer 2017. [Epub ahead of print].
Studaway A, Ojha RP, Brinkman TM, Zhang N, Baassiri M, Banerjee P, Ehrhardt MJ, Srivastava D, Robison LL, Hudson MM, & Krull KR. Chronic hepatitis C virus infection and neurocognitive function in adult survivors of childhood cancer. Cancer 2017. [Epub ahead of print].
Cheung YT, Chemaitilly W, Mulrooney DA, Brinkman TM, Liu W, Banerjee P, Srivastava D, Pui CH, Robison LL, Hudson MM, & Krull KR. Association between dehydroepiandrosterone-sulfate and attention in long-term survivors of childhood acute lymphoblastic leukemia treated with only chemotherapy. Psychoneuroendocrinology 76:114-118, 2016.
Banerjee P, Leu K, Harris RJ, Cloughesy TF, Lai A, Nghiemphu PL, Pope WB, Bookheimer SY, Ellingson BM. Association between lesion location and language function in adult glioma using voxel-based lesion-symptom mapping. NeuroImage: Clinical 9:617-624, 2015.
Banerjee P, White DA. Clinical assessment of organizational strategy: An examination of healthy adults. Psychological Assessment 27(2):726-732, 2015.
Banerjee P, Grange DK, Steiner RD, White DA. Executive strategic processing during verbal fluency performance in children with phenylketonuria. Child Neuropsychology 17(2):105-117, 2011.
Karzon R, Banerjee P. Animated toys versus video reinforcement in 16 to 24 month-old children in a clinical setting. American Journal of Audiology 19:91-99, 2010.
Cuff A, Banerjee P, Azhdam B. Managing for oncology growth, Volume II: Best practices for expanding access to care. Washington, DC: The Advisory Board Company. 232p, 2008.
Cuff A, Banerjee P, Azhdam B. Managing for oncology growth, Volume I: Best practices for increasing efficiency. Washington, DC: The Advisory Board Company. 214p, 2007.
Contos B, Pfenninger D, Banerjee P, Martsolf GR, Measells K. Outlook for medical cardiology: Five-year technology and business assessment. Washington, DC: The Advisory Board Company. 249p, 2007.
Siegler A, Cuff A, Banerjee P, Martsolf GR. Cancer center of the future: Strategic blueprint and management imperatives for new therapies and services. Washington, DC: The Advisory Board Company. 263p, 2006.
Pfenninger D, Banerjee P. Quality-based competition: Best practices for optimizing cardiac quality reporting. Washington, DC: The Advisory Board Company. 149p, 2006.
Herrington J, Zhou YP, Bugianesi RM, Duslki PM, Feng Y, Warren VA, Smith MM, Kohler MG, Garsky VM, Sanchez M, Wagner M, Raphaelli K, Banerjee, P, Ahaghotu C, Wunderler D, Priest BT, Mehl JT, Garcia ML, McManus OB, Kaczorowski GJ, Slaughter RS. Blockers of the delayed-rectifier potassium current in pancreatic β-cells enhance glucose-dependent insulin secretion. Diabetes 55:1034-1042, 2006.
Yan L, Herrington J, Goldberg E, Dulski PM, Bugianesi RM, Slaughter RS, Banerjee P, Brochu RM, Priest BT, Kaczorowski GJ, Rudy B, Garcia ML. Stichodactyla helianthus peptide, a pharmacological tool for studying Kv3.2 channels. Molecular Pharmacology 67(5):1513-1521, 2005.
Banerjee P. Recognition of c-ros oncogene inhibition with a FRET-based reporter construct. MIT Undergraduate Research Journal 10:52-57, 2004.
Last update: August 2017